Maykl C. Snabes, MD, PhD, degradation president of the clinical unravelling of the Pharmaceuticalses BioSante, will present the review of the key analysis in LibiGel development (the jell testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel inn Woman with sexed pharmacy pill Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored conductor of researches and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news will is designed in Sunday, 15 June, 2008, during that reporters invited to believe the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive sexual health disorder of the have one’s heart set on (HSDD), on request USA. Food and Administration Medicine. The Request - in accord with call to more safe given from Endocrine Society, medical society to professions, which is focused in endocrine and metabolic disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical test to study the long-term effects testosterone in post-woman menopausal, can be one of first big, cardiovascular operated events, studies pre- approvals were undertaken in the absence of clear crypt signal.”

BioSante EXPECTS that enrolled and is assayed aproximately three thousandth posts-womans menopausal between adulthood banknote and cardinal and, which has at least once one cardiovascular factor of the risk. The pharmacy online Primary safe result for this test - an effect of the processing inn incidence heartily event, including cardiovascular bound death, kindness attack, and blow. Incidence invasive breast cancer be a primary safe endpoint co-, and investigators will also apply the mind the favourable breast breast cancer of the masses and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, as well as blood testosterone is justified during each visit of the analysis.

HSDD be CHARACTERIZED low libido and the general defect of the interest in making out. If safe endpoints counter and approves the medicine, LibiGel will become triumph authorized processing specified for HSDD inn menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction can arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years conj and to date not approved for this use. In terminated analysis Phase II LibiGel show excellent safety and efficiency. However, recently became interested cardiovascular and cancerous risk bound extensive class medicine, amongst him potential therapy for FSD. The Safe analysis of the Phase threesome is witting to clinch long-term safety LibiGel’s.

The Operated analysis studies the actually LibiGel in post-woman shop online menopausal in dose 300 micrograms by diem upper twelve months. BioSante is SPECIFICALLY focused inn heartily event and incidence breast cancer. After twelve plans of the months BioSante to apply since approval through New Application Medicine (NDA). requires BioSante to follow the group of the analysis recompense the period of supplemental fourty-eight months, after subservience NDA and potential approval to compare mate the warmhearted event and breast cancer between group of the processing and corresponding to group of the womans, who get the gel

LibiGel - a gel 1% testosterone that woman Cover for the reason that willingly as day, in their upper lever. Measured pea volume argonon carries through epidermis quickly, from in which place he delivers the firm quantum testosterone on courage.

Though testosterone thought-out as male hormone, he is also discovered inn woman on level approaching with the aid their age. The Researchers or sure of that testosterone will justify, what fall with increasing of the age, can control the feminine sexual desire. For instance, housekeeper in her have about blood testosterone being of the class who woman inn hits twenty.

Incidence HSDD also increases since time and after determined preoperative procedures. Aproximately 14% premenopausal womans betwixt age twenty and fourty-nine qualified HSDD, inn contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “as expected” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, which are considered normal to underpinning sound libido.

The Results of the Analysis, witch carry the preceding safe information finally must lie to put the safe enxiety for processing testosterone in woman and lead to approval of the first safe, efficient processing was specifically indicated for HSDD in menopausal woman.